XNYSOSCR
Market cap3.24bUSD
Jan 08, Last price
15.29USD
1D
6.25%
1Q
-11.82%
IPO
-52.32%
Name
Oscar Health Inc
Chart & Performance
P/E
—
P/S
0.55
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
5.86b
+42.11%
Net income
-271m
L-55.59%
CFO
-272m
L
Earnings
Feb 05, 2025
Profile
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 5,862,869 42.11% | 4,125,584 114.77% | |||
Cost of revenue | 339,716 | 309,783 | |||
Unusual Expense (Income) | |||||
NOPBT | 5,523,153 | 3,815,801 | |||
NOPBT Margin | 94.21% | 92.49% | |||
Operating Taxes | 3,294 | (523) | |||
Tax Rate | 0.06% | ||||
NOPAT | 5,519,859 | 3,816,324 | |||
Net income | (270,728) -55.59% | (609,552) 6.67% | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 1,299 | ||||
BB yield | -0.25% | ||||
| Debt | |||||
Debt current | |||||
Long-term debt | 298,777 | 297,999 | |||
Deferred revenue | |||||
Other long-term liabilities | 67,574 | 72,280 | |||
Net debt | (2,626,680) | (4,055,170) | |||
| Cash flow | |||||
Cash from operating activities | (272,159) | 380,349 | |||
CAPEX | (25,577) | (29,012) | |||
Cash from investing activities | 577,187 | (226,519) | |||
Cash from financing activities | 6,446 | 301,110 | |||
FCF | 5,517,817 | 3,982,120 | |||
| Balance | |||||
Cash | 2,560,148 | 2,955,882 | |||
Long term investments | 365,309 | 1,397,287 | |||
Excess cash | 2,632,314 | 4,146,890 | |||
Stockholders' equity | (2,873,254) | (2,613,684) | |||
Invested Capital | 4,045,722 | 3,876,363 | |||
ROIC | 139.35% | 130.02% | |||
ROCE | 471.07% | 302.20% | |||
| EV | |||||
Common stock shares outstanding | 221,655 | 212,475 | |||
Price | 9.15 271.95% | 2.46 -68.66% | |||
Market cap | 2,028,148 288.02% | 522,688 -62.80% | |||
EV | (596,382) | (3,530,466) | |||
EBITDA | 5,553,847 | 3,831,084 | |||
EV/EBITDA | |||||
Interest | 24,603 | 22,623 | |||
Interest/NOPBT | 0.45% | 0.59% | |||